Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes.

Amyotrophic lateral sclerosis (ALS) is a progressive, fatal, motor neuron disease with no effective long-term treatment options. Recently, TDP-43 has been identified as a key protein in the pathogenesis of some cases of ALS. Although the role of TDP-43 in motor neuron degeneration is not yet known,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sarah J Parker, Jodi Meyerowitz, Janine L James, Jeffrey R Liddell, Takashi Nonaka, Masato Hasegawa, Katja M Kanninen, SinChun Lim, Brett M Paterson, Paul S Donnelly, Peter J Crouch, Anthony R White
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/3b5512010cb641b9b53449d57880b60f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3b5512010cb641b9b53449d57880b60f
record_format dspace
spelling oai:doaj.org-article:3b5512010cb641b9b53449d57880b60f2021-11-18T07:09:48ZInhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes.1932-620310.1371/journal.pone.0042277https://doaj.org/article/3b5512010cb641b9b53449d57880b60f2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22879928/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Amyotrophic lateral sclerosis (ALS) is a progressive, fatal, motor neuron disease with no effective long-term treatment options. Recently, TDP-43 has been identified as a key protein in the pathogenesis of some cases of ALS. Although the role of TDP-43 in motor neuron degeneration is not yet known, TDP-43 has been shown to accumulate in RNA stress granules (SGs) in cell models and in spinal cord tissue from ALS patients. The SG association may be an early pathological change to TDP-43 metabolism and as such a potential target for therapeutic intervention. Accumulation of TDP-43 in SGs induced by inhibition of mitochondrial activity can be inhibited by modulation of cellular kinase activity. We have also found that treatment of cells and animal models of neurodegeneration, including an ALS model, with bioavailable bis(thiosemicarbazonato)copper(II) complexes (Cu(II)(btsc)s) can modulate kinase activity and induce neuroprotective effects. In this study we examined the effect of diacetylbis(-methylthiosemicarbazonato)copper(II) (Cu(II)(atsm)) and glyoxalbis(-methylthiosemicarbazonato)copper(II) (Cu(II)(gtsm)) on TDP-43-positive SGs induced in SH-SY5Y cells in culture. We found that the Cu(II)(btsc)s blocked formation of TDP-43-and human antigen R (HuR)-positive SGs induced by paraquat. The Cu(II)(btsc)s protected neurons from paraquat-mediated cell death. These effects were associated with inhibition of ERK phosphorylation. Co-treatment of cultures with either Cu(II)(atsm) or an ERK inhibitor, PD98059 both prevented ERK activation and blocked formation of TDP-43-and HuR-positive SGs. Cu(II)(atsm) treatment or ERK inhibition also prevented abnormal ubiquitin accumulation in paraquat-treated cells suggesting a link between prolonged ERK activation and abnormal ubiquitin metabolism in paraquat stress and inhibition by Cu. Moreover, Cu(II)(atsm) reduced accumulation of C-terminal (219-414) TDP-43 in transfected SH-SY5Y cells. These results demonstrate that Cu(II)(btsc) complexes could potentially be developed as a neuroprotective agent to modulate neuronal kinase function and inhibit TDP-43 aggregation. Further studies in TDP-43 animal models are warranted.Sarah J ParkerJodi MeyerowitzJanine L JamesJeffrey R LiddellTakashi NonakaMasato HasegawaKatja M KanninenSinChun LimBrett M PatersonPaul S DonnellyPeter J CrouchAnthony R WhitePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 8, p e42277 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sarah J Parker
Jodi Meyerowitz
Janine L James
Jeffrey R Liddell
Takashi Nonaka
Masato Hasegawa
Katja M Kanninen
SinChun Lim
Brett M Paterson
Paul S Donnelly
Peter J Crouch
Anthony R White
Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes.
description Amyotrophic lateral sclerosis (ALS) is a progressive, fatal, motor neuron disease with no effective long-term treatment options. Recently, TDP-43 has been identified as a key protein in the pathogenesis of some cases of ALS. Although the role of TDP-43 in motor neuron degeneration is not yet known, TDP-43 has been shown to accumulate in RNA stress granules (SGs) in cell models and in spinal cord tissue from ALS patients. The SG association may be an early pathological change to TDP-43 metabolism and as such a potential target for therapeutic intervention. Accumulation of TDP-43 in SGs induced by inhibition of mitochondrial activity can be inhibited by modulation of cellular kinase activity. We have also found that treatment of cells and animal models of neurodegeneration, including an ALS model, with bioavailable bis(thiosemicarbazonato)copper(II) complexes (Cu(II)(btsc)s) can modulate kinase activity and induce neuroprotective effects. In this study we examined the effect of diacetylbis(-methylthiosemicarbazonato)copper(II) (Cu(II)(atsm)) and glyoxalbis(-methylthiosemicarbazonato)copper(II) (Cu(II)(gtsm)) on TDP-43-positive SGs induced in SH-SY5Y cells in culture. We found that the Cu(II)(btsc)s blocked formation of TDP-43-and human antigen R (HuR)-positive SGs induced by paraquat. The Cu(II)(btsc)s protected neurons from paraquat-mediated cell death. These effects were associated with inhibition of ERK phosphorylation. Co-treatment of cultures with either Cu(II)(atsm) or an ERK inhibitor, PD98059 both prevented ERK activation and blocked formation of TDP-43-and HuR-positive SGs. Cu(II)(atsm) treatment or ERK inhibition also prevented abnormal ubiquitin accumulation in paraquat-treated cells suggesting a link between prolonged ERK activation and abnormal ubiquitin metabolism in paraquat stress and inhibition by Cu. Moreover, Cu(II)(atsm) reduced accumulation of C-terminal (219-414) TDP-43 in transfected SH-SY5Y cells. These results demonstrate that Cu(II)(btsc) complexes could potentially be developed as a neuroprotective agent to modulate neuronal kinase function and inhibit TDP-43 aggregation. Further studies in TDP-43 animal models are warranted.
format article
author Sarah J Parker
Jodi Meyerowitz
Janine L James
Jeffrey R Liddell
Takashi Nonaka
Masato Hasegawa
Katja M Kanninen
SinChun Lim
Brett M Paterson
Paul S Donnelly
Peter J Crouch
Anthony R White
author_facet Sarah J Parker
Jodi Meyerowitz
Janine L James
Jeffrey R Liddell
Takashi Nonaka
Masato Hasegawa
Katja M Kanninen
SinChun Lim
Brett M Paterson
Paul S Donnelly
Peter J Crouch
Anthony R White
author_sort Sarah J Parker
title Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes.
title_short Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes.
title_full Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes.
title_fullStr Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes.
title_full_unstemmed Inhibition of TDP-43 accumulation by bis(thiosemicarbazonato)-copper complexes.
title_sort inhibition of tdp-43 accumulation by bis(thiosemicarbazonato)-copper complexes.
publisher Public Library of Science (PLoS)
publishDate 2012
url https://doaj.org/article/3b5512010cb641b9b53449d57880b60f
work_keys_str_mv AT sarahjparker inhibitionoftdp43accumulationbybisthiosemicarbazonatocoppercomplexes
AT jodimeyerowitz inhibitionoftdp43accumulationbybisthiosemicarbazonatocoppercomplexes
AT janineljames inhibitionoftdp43accumulationbybisthiosemicarbazonatocoppercomplexes
AT jeffreyrliddell inhibitionoftdp43accumulationbybisthiosemicarbazonatocoppercomplexes
AT takashinonaka inhibitionoftdp43accumulationbybisthiosemicarbazonatocoppercomplexes
AT masatohasegawa inhibitionoftdp43accumulationbybisthiosemicarbazonatocoppercomplexes
AT katjamkanninen inhibitionoftdp43accumulationbybisthiosemicarbazonatocoppercomplexes
AT sinchunlim inhibitionoftdp43accumulationbybisthiosemicarbazonatocoppercomplexes
AT brettmpaterson inhibitionoftdp43accumulationbybisthiosemicarbazonatocoppercomplexes
AT paulsdonnelly inhibitionoftdp43accumulationbybisthiosemicarbazonatocoppercomplexes
AT peterjcrouch inhibitionoftdp43accumulationbybisthiosemicarbazonatocoppercomplexes
AT anthonyrwhite inhibitionoftdp43accumulationbybisthiosemicarbazonatocoppercomplexes
_version_ 1718423846537658368